Eric M. Paradise, Ph.D.
Affiliations: | 2006 | University of California, Berkeley, Berkeley, CA, United States |
Area:
Metabolic engineering of microorganismsGoogle:
"Eric Paradise"Mean distance: 9.56 | S | N | B | C | P |
Parents
Sign in to add mentorJay D. Keasling | grad student | 2006 | UC Berkeley | |
(Engineering Saccharomyces cerevisiae for high-level terpenoid production.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Ro DK, Ouellet M, Paradise EM, et al. (2008) Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid. Bmc Biotechnology. 8: 83 |
Kirby J, Romanini DW, Paradise EM, et al. (2008) Engineering triterpene production in Saccharomyces cerevisiae-beta-amyrin synthase from Artemisia annua. The Febs Journal. 275: 1852-9 |
Paradise EM, Kirby J, Chan R, et al. (2008) Redirection of flux through the FPP branch-point in Saccharomyces cerevisiae by down-regulating squalene synthase. Biotechnology and Bioengineering. 100: 371-8 |
Shiba Y, Paradise EM, Kirby J, et al. (2007) Engineering of the pyruvate dehydrogenase bypass in Saccharomyces cerevisiae for high-level production of isoprenoids. Metabolic Engineering. 9: 160-8 |
Newman JD, Marshall J, Chang M, et al. (2006) High-level production of amorpha-4,11-diene in a two-phase partitioning bioreactor of metabolically engineered Escherichia coli. Biotechnology and Bioengineering. 95: 684-91 |
Ro DK, Paradise EM, Ouellet M, et al. (2006) Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature. 440: 940-3 |